Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan + Amlodipine SBP Targets in Hypertension
NCT00523549Phase 4Completed
- Sponsor
- Novartis
- Start
- Nov 2006
- Primary completion
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of valsartan, amlodipine in hypertension (HTN), diastolic dysfunction, sponsored by Novartis. Started Nov 2006; status: completed.
02
Drugs
valsartanamlodipine
03
Conditions
hypertension (HTN)diastolic dysfunction
Beyond the preview
Go deeper on NCT00523549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00523549.